Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

By sjmartinez • November 11, 2023

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis. Rheumatol Ther. 2023 Nov 10. doi: 10.1007/s40744-023-00618-1. Epub ahead of print. PMID: 37948030.

Tags: Harbor UCLA, Molecular signature, Precision medicine, Publications, Response classifier, Rheumatoid arthritis, Rheumatology, Treatment selection

In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic Approach

Youssef EG, Elnesr K, Hanora A. In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using[...]

Effect of High Altitude on Small Pulmonary Vein and Artery Volume in the COPDGene Cohort: Towards Better Understanding of Lung Physiology and Pulmonary Disease

Kwee AKAL, Pompe E, Gallardo Estrella L, Charbonnier JP, Humphries SM, Tiddens HAWM, Crapo JD, Casaburi R, de Jong PA, Lynch DA, Mohamed Hoesein FAA.[...]

The Association of Niacin Use with Kidney Outcomes and Mortality

Takahashi R, Bui TA, Elali I, Tran D, Sumida K, Thomas F, Dukkipati R, Shah A, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Takahashi R. The[...]